Arterial Stent Market was valued at USD 7.5 Billion in 2022 and is projected to reach USD 10.6 Billion by 2030, growing at a CAGR of 4.6% from 2024 to 2030.
The global arterial stent market is currently valued at approximately $12 billion in 2025 and is projected to grow at a compound annual growth rate CAGR of 6.8% from 2025 to 2035. This growth is driven by the rising prevalence of cardiovascular diseases increasing demand for minimally invasive surgical procedures and advancements in stent technology. Innovations such as drug eluting stents DES bioresorbable stents and advanced imaging technologies are significantly influencing the market landscape. Moreover the aging global population and lifestyle related factors such as obesity and diabetes are contributing to the increased demand for arterial stents.
Get an In-Depth Research Analysis of the Global Arterial Stent Market Size And Forecast [2025-2032]
Increasing incidence of cardiovascular diseases worldwide.
Technological advancements in stent designs including biodegradable and drug eluting stents.
Rising preference for minimally invasive procedures due to shorter recovery times and lower risk.
Growing investments in healthcare infrastructure in emerging economies.
High costs associated with advanced stents and related procedures.
Stringent regulatory approvals and compliance requirements.
Potential complications such as restenosis and thrombosis limiting adoption in some cases.
Expanding healthcare access in developing regions particularly in Asia Pacific and Africa.
Integration of artificial intelligence AI and machine learning for precision treatment planning.
Development of next generation stents with enhanced biocompatibility and customization.
Coronary Artery Disease: Dominates the market driven by the high prevalence of coronary blockages and the widespread adoption of drug eluting stents.
Peripheral Artery Disease: Growing segment attributed to increased awareness and advancements in stent technology.
Hospitals: Account for the largest share owing to their capacity to perform complex procedures.
Ambulatory Surgical Centers: Witnessing rapid growth due to cost effectiveness and convenience.
Specialized Clinics: Focus on outpatient stent placements offering personalized care.
North America: Leads the market due to advanced healthcare infrastructure and high awareness.
Europe: Significant contributor with a focus on research and innovation.
Asia Pacific: Fastest growing region driven by a large patient pool and rising investments in healthcare.
Latin America and Middle East & Africa: Emerging markets with substantial growth potential.
Boston Scientific Corporation: Offers a wide range of innovative stent solutions including the Synergy Bioabsorbable Polymer Stent.
Abbott Laboratories: Known for its Absorb GT1 bioresorbable stent and Xience family of drug eluting stents.
Medtronic: Provides a comprehensive portfolio of coronary and peripheral stents including Resolute Onyx DES.
BIOTRONIK: Focuses on advanced stent technologies such as Orsiro DES.
Terumo Corporation: Specializes in minimally invasive devices including high performance stents.
Emerging trends and innovations in the arterial stent market include:
Bioresorbable Stents: Designed to dissolve naturally reducing long term complications.
Drug Coated Balloons: Offering an alternative to traditional stents in specific cases.
AI Driven Diagnostics: Enhancing precision in stent placement and post operative monitoring.
Collaborative Research: Partnerships between medical device companies and research institutions to accelerate innovation.
Supply Chain Disruptions: Impacting timely delivery of stents and raw materials.
Pricing Pressures: Due to intense competition and regulatory constraints.
Regulatory Hurdles: Delays in approval processes affecting product launches.
Streamlining supply chains through robust logistics and local manufacturing facilities.
Adopting value based pricing models to balance affordability and profitability.
Engaging with regulatory bodies early in the product development cycle for smoother approvals.
The arterial stent market is poised for significant growth driven by advancements in technology increased healthcare access and rising awareness about cardiovascular health. The integration of AI and machine learning coupled with the development of next generation stents will shape the market's future trajectory. By 2035 the market is expected to surpass $25 billion with Asia Pacific emerging as a key growth region.
North America currently leads the market followed by Europe and Asia Pacific.
Arterial stents are primarily used for treating coronary artery disease and peripheral artery disease.
Challenges include supply chain disruptions pricing pressures and regulatory hurdles.
Key players include Boston Scientific Corporation Abbott Laboratories Medtronic BIOTRONIK and Terumo Corporation.
The market is expected to grow at a CAGR of 6.8% reaching over $25 billion by 2035 with significant contributions from emerging markets and technological advancements.
Abbott Laboratories
Cordis Corporation
Boston Scientific Corporation
C.R. Bard Inc.
Cook Medical
Medtronic
Gore Medical
Lifetech Scientific
Biosensors International Group Ltd.
Biotronik AG
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Arterial Stent Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Arterial Stent Market
Iliac Artery
Carotid Artery
Coronary Artery
Femoral & Popliteal Artery
Other
Based on Types the Market is categorized into Below types that held the largest Arterial Stent market share In 2023.
Coronary Stents
Peripheral Stents
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Arterial Stent Market Research Analysis
1. Introduction of the Global Arterial Stent Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Arterial Stent Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Arterial Stent Market, By Type
6. Global Arterial Stent Market, By Application
7. Global Arterial Stent Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Arterial Stent Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/